WEST CALDWELL, N.J., April 26 /PRNewswire-FirstCall/ -- Pro-Tect Pharmaceuticals, Inc. (PRTT) announced today that it has completed the acquisition of multiple patents and patents-pending from Nectid, Inc., that enable three revolutionary drug delivery technologies.
